Parkman Healthcare Partners’s Rapid Micro Biosystems RPID Stock Holding History

Parkman Healthcare Partners’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-354,465	Closed	-$1.03M	–	107
2025 Q4	$1.03M	Sell	354,465 -558,978	-61%	-$1.94M	0.1%	92
2025 Q3	$3.05M	Hold	913,443	–	–	0.32%	75
2025 Q2	$3.15M	Buy	913,443 +177,822	+24%	+$516K	0.36%	71
2025 Q1	$1.94M	Buy	+735,621	New	+$1.68M	0.23%	76
2022 Q1	–	Sell	-100,000	Closed	-$1.06M	–	91
2021 Q4	$1.06M	Buy	+100,000	New	+$1.56M	0.23%	74

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

EFA

Evernest Financial Advisors Carmel, Indiana $481M AUM 19.97% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LCM

Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkman Healthcare Partners's RPID Position: Q1 2026 in Review

Parkman Healthcare Partners sold out of Rapid Micro Biosystems (RPID) in Q1 2026, closing a stake of 354,465 shares — an estimated $1.03M sold.

Parkman Healthcare Partners first reported a position in RPID in Q4 2021 and held it in 5 quarters. The position peaked at $3.15M in Q2 2025. 46 funds tracked by Wall St. Rank hold RPID as of Q1 2026.

Parkman Healthcare Partners reported no remaining Rapid Micro Biosystems position as of Q1 2026 after selling out during the quarter.
Parkman Healthcare Partners sold 354,465 Rapid Micro Biosystems shares in Q1 2026, an estimated $1.03M.
Parkman Healthcare Partners first reported a position in Rapid Micro Biosystems in Q4 2021 and held it in 5 quarters.
Parkman Healthcare Partners's Rapid Micro Biosystems position peaked at $3.15M in Q2 2025.
46 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.